Arginine

growth hormone releasing hormone ; Homo sapiens







112 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 11834428 The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. 2002 Feb 4
52 12153607 Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. 2002 Aug 1
53 11895217 Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. 2001 Dec 1
54 10664524 Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine. 2000 Feb 6
55 10718826 Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction. 2000 Mar 2
56 10720081 Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. 2000 Mar 1
57 10800760 GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. 2000 Feb 1
58 10800762 Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children. 2000 Feb 3
59 11004017 Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise. 2000 Oct 1
60 11061509 Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. 2000 Oct 2
61 11061526 Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. 2000 Oct 2
62 11202226 Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span. 2000 1
63 10199767 The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. 1999 Apr 3
64 10401710 Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen. 1999 May 1
65 10443652 Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. 1999 Aug 1
66 9524798 Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome. 1998 Mar-Apr 1
67 9557822 Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. 1998 Feb 1
68 9589665 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. 1998 May 2
69 10083901 Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. 1998 Jul 2
70 10993592 Diagnosis of GH deficiency in adults. 1998 Feb 1
71 11081183 Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. 1998 Apr 4
72 9178029 Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults. 1997 Apr 2
73 9202399 Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. 1997 May 16 1
74 9302373 Methionine potentiates both basal and GHRH-induced GH secretion in children. 1997 Jul 2
75 9438917 Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients. 1997 Nov 1
76 8616534 New approach to the diagnosis of growth hormone deficiency in adults. 1996 Mar 4
77 8626871 The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus. 1996 May 4
78 8690107 Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women. 1996 Aug 1
79 8793891 Function of the GH/IGF-1 axis in healthy middle-aged male runners. 1996 Jun 1
80 8980159 Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. 1996 Nov 1
81 9004172 GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine. 1996 Nov-Dec 5
82 7581965 Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. 1995 Oct 3
83 7729789 Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. 1995 Jan 1
84 7735336 Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. 1995 Feb 3
85 7850007 Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging. 1995 Jan 4
86 8736266 Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. 1995 Dec 4
87 7880938 Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. 1994 Nov 15 1
88 8006330 Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects. 1994 Feb 3
89 8033372 Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. 1994 Jun 2
90 8051337 Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. 1994 Mar 2
91 8121306 Interaction of free fatty acids and arginine on growth hormone secretion in man. 1994 Feb 3
92 8103770 Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. 1993 Sep 3
93 8227981 Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. 1993 Jul-Aug 3
94 8241653 Oral administration of arginine enhances the growth hormone response to growth hormone releasing hormone in short children. 1993 Oct 1
95 8316397 Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children. 1993 Mar 4
96 8344645 Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? 1993 Jun 1
97 1307747 Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism. 1992 1
98 1355580 Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man. 1992 Sep 6
99 1479149 A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging. 1992 Oct 1
100 1543013 GH response to GHRH, insulin, clonidine and arginine after GHRH pretreatment in children. 1992 Feb 2